¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"phase shift effect"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • negative phase
    1. À½¼º»ó 2. Ç×ü°¨¼Ò±â
  • oral phase
    ±¸°­±â
  • orgasmic phase
    ¼º±ØÄ¡±â
  • ovogenetic phase
    ³­Àڹ߻ý±â
  • phase difference
    À§»óÂ÷
  • phase display
    À§»óÇ¥½Ã
  • phase encoding gradient
    À§»óºÎȣȭ±â¿ï±â
  • phase encoding step
    À§»óºÎȣȭ´Ü°è
  • phase image
    À§»ó¿µ»ó
  • phase offset multiplanar imaging
    À§»ó¿ÀÇÁ¼Â´Ù¸é¿µ»ó
  • phase ratio
    »óºñ
  • phase reversal
    À§»ó¹ÝÀü
  • phase rule
    »óÀǹýÄ¢, »ó±ÔÄ¢
  • phase transition
    À§»óÀüÀÌ
  • phase wraparound artifact
    À§»óµÑ·¯°ãħÀΰø¹°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • phase constant
    À§»ó»ó¼ö
  • phase contrast
    À§»ó´ëÁ¶
  • phase curve
    À§»ó°î¼±
  • death phase
    »ç¸ê±â
  • delayed sleep phase
    Áö¿¬¼ö¸éÀ§»ó
  • delayed sleep phase syndrome
    ¼ö¸éÀ§»óÁö¿¬ÁõÈıº
  • depressive phase
    ¿ì¿ï»ó
  • diastolic phase
    È®Àå±â, À̿ϱâ
  • diplotene phase
    °ã¼¶À¯±â
  • diurnal phase
    ÁÖ°£»ó
  • phase delay
    À§»óÁö¿¬
  • phase difference
    À§»óÂ÷
  • phase display
    À§»óÇ¥½Ã
  • phase encode direction
    À§»óºÎȣȭ¹æÇâ
  • ejection phase
    ¹ÚÃâ±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • phase encoding step
    À§»ó ºÎÈ£ ´Ü°è
  • phase evolution of fat suppression
    À§»ó ¼±È¸ Áö¹æ ¾ïÁ¦
  • phase frequency swap
    À§»ó Á֯ļö ±³È¯
  • phase image
    À§»ó ¿µ»ó
  • phase mismapping
    À§»ó ¿ÀÁöµµÀÛ¼º
  • phase of cornification
    °¢Áú±â
  • phase of decline
    °¨Åð±â, °¨¼Ò±â
  • phase of desquamation
    ¹Ú¸®±â
  • phase of incornification
    ºñ°¢Áú±â
  • phase of life problem
    ÀλýÁÖ±âÀÇ ¹®Á¦
  • phase of meditation
    Àẹ±â°£(íÖÜÑÑ¢Êà).
  • phase of rapid filling
    ±Þ¼ÓÃæ¸¸±â(ÐááÜ õöØ»Ðï).
  • phase of relaxation
    À̿ϱâ(ì¬èÐÐï).
  • phase of shortening
    ´ÜÃà±â(Ó­õêÑ¢).
  • phase offset multiplannar (POMP) imaging
    À§»ó ¿ÀÇÁ¼Â ´Ù¸é ¿µ»ó
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • latitude effect
    À§µµÈ¿°ú(ÊÙÌ·Ë­).
  • mach effect
    ¸¶ÇÏÇö»ó
  • magnetic field effect
    ÀÚÀåÈ¿°ú
  • magnetization transfer effect
    ÀÚÈ­ Àü´Þ È¿°ú
  • masking effect
    ÀºÆóÈ¿°ú(ëßøÌüùÍý).
  • mass effect
    Áú·®È¿°ú
  • mass effect
    Á¾±«¿µÇâ, -È¿°ú
  • mesomeric effect
    °ø¸íÈ¿°ú
  • misregistration effect
    ¿Àµî·Ï È¿°ú
  • mottled effect
    ¾ó·è¹«´Ì
  • muscarinic effect
    ¹«½ºÄ«¸°¼ºÈ¿°ú(¡­àõüùÍý).
  • muscarinic effect
    ¹«½ºÄ«¸°¾çÈ¿°ú (¡­åÆüùÍý).
  • myocardium,aging effect
    ³ëÈ­Çö»ó(ÖÕûùúÞßÚ)
  • nicotinic effect
    ´ÏÄÚÆ¾ÀÛ¿ë, ´ÏÄÚÆ¾È¿°ú.
  • nicotinic effect
    ´ÏÄÚÆ¾(¼º)È¿°ú.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
ROESY rotating frame Overhauser effect spectroscopy
SDE specific dynamic effect; subdural empyema
SE saline enema; sanitary engineering; side effect; smoke exposure; solid extract; sphenoethmoidal; spi...
TEE thermic effect of exercise; total energy expenditure; transesophageal echocardiography; tyrosine eth...
TEF thermic effect of food; thyrotroph embryonic factor; tracheoesophageal fistula; transcriptional enha...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
2D NOE Two-dimensional nuclear Overhauser effect
AME antimicrobial effect
CPE cytopathogenic effect
EC(50) effect
EGb 761 effect of Ginkgo biloba extract
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • second influencing effect
    ÀÌÂ÷ È¿°ú
  • sedative effect
    ÁøÁ¤ È¿°ú
  • sensory effect
    °¨°¢ È¿°ú
  • shearing effect
    Àü´Ü È¿°ú
  • shimmering effect : ÈíÀÎ ½Ã ÄÝ·¹½ºÅ×·ÑÀÌ °áÁ¤ÀÌ Æ÷ÇԵǾî ÀÖ´Â ¿¯Àº ¹Ð¤ »öÀÇ ¾×ü°¡ ³ª¿À¸ç ÀÌ ÄÝ·¹½ºÅ×·Ñ °áÁ¤Àº À¯¸®°ü¿¡ ³»¿ë¹°ÀÎ ¾×ü¸¦ ³Ö¾î ±¤¼± ¾Æ·¡¿¡¼­ ºñÃ纸¸é Ư¡ÀûÀÎ ºûÀ» ³»´Â Çö»ó.

    shimming

    º¸Á¤
  • sialogogic effect
    Ÿ¾× ºÐºñ ÃËÁø È¿°ú
  • side effect
    ºÎÀÛ¿ë
    »ç¿ëµÈ ¾àǰÀ̳ª ¾àÁ¦°¡ ¸ñÀû ÀÌ¿ÜÀÇ ´Ù¸¥ °á°ú, Áï ¹Ý´ë ÀÛ¿ëÀ¸·Î ¾à¹°¿¡ ´ëÇÑ À¯ÇØ ÀÛ¿ë, ƯÈ÷ ±× Åõ¿©·Î È¿´ÉÀ» Ãß±¸ÇÏ´Â °Í°ú ´Ù¸¥ Á¶Á÷À̳ª ±â°ü °èÅë¿¡ ¹ÌÄ¡´Â ÇØ·Î¿î ¿µÇâ°ú °°Àº °Í.
  • siphonage effect
    ½ÎÀÌÆù È¿°ú
  • snow-storm effect
    ´«º¸¶ó È¿°ú
  • somogyi effect
    ¼Ò¸ð±â È¿°ú
    Á¦ 1Çü ´ç´¢º´ ȯÀÚ¿¡¼­ ¾ß°£¿¡ ÀúÇ÷´çÁõÀÌ ¹ß»ýÇÏ´Â °æ¿ì ±æÇ× Á¶Àý È£¸£¸óÀÇ ºÐºñ¸¦ ÀÚ±ØÇÏ¿©
  • stochastic effect
    È®·üÀû È¿°ú
  • suction effect
    ÈíÀÔ È¿°ú
  • suffing effect
    À̿ ¸ÅÀÔ È¿°ú
    À̿ ±³È¯¿¡ ÀÇÇÑ µµÀçÀÇ °­È­ È¿°ú.
  • systemic adverse effect
    Àü½Å¼º ºÎÀÛ¿ë
  • T1 shortening effect
    T1 ´ÜÃà È¿°ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
phase-contrast microscope <instrument> A specially constructed microscope that has a special condenser and objective containing a phase-shifting ring whereby small differences in index of refraction are made visible as intensity or contrast differences in the image; particularly useful for examining structural details in transparent specimens such as living or unstained cells and tissues.
(05 Mar 2000)
phase contrast microscopy <investigation> A simple nonquantitative form of interference micoscopy of great utility in visualising live cells. Small differences in optical path length due to differences in refractive index and thickness of structures are visualised as differences in light intensity.
(18 Nov 1997)
phase, crystal <microscopy> A specific crystal structure, usually given a name.
(05 Aug 1998)
phase encoding In magnetic resonance imaging, the technique of inducing a gradient in the magnetic field in the Y-axis to induce phase differences with location.
Synonym: gradient encoding.
(05 Mar 2000)
phase I block Inhibition of nerve impulse transmission across the myoneural junction associated with depolarisation of the motor endplate, as in the muscle paralysis produced by succinylcholine.
(05 Mar 2000)
phase I clinical trial <pharmacology> The earliest stage clinical trial for studying an experimental drug in humans. Phase I trials are generally comparatively small and are used to determine toxicity and maximum dose.
They provide an initial evaluation of a drug's safety and pharmacokinetics-how the drug is absorbed, what tissues it reaches and how long it takes to leave the body. Such studies also usually test various doses of the drug (dose-ranging) to obtain an indication of the appropriate dose to use in later studies.
The patients in these trials usually have advanced disease and have already received best available chemotherapy, therefore, seeing a repose is significant partially because this means there is a lack of cross-resistance between two anti-cancer drugs.
(31 Dec 1997)
phase II block Inhibition of nerve impulse transmission across the myoneural junction unaccompanied by depolarisation of the motor endplate, as in the muscle paralysis produced by tubocurarine.
(05 Mar 2000)
phase II clinical trial <pharmacology> Usually focus on the activity of the new product as a single agent in a noncomparative, open study.
(31 Dec 1997)
phase III clinical trial <pharmacology> An advanced stage clinical trial that should conclusively show how well a drug works as compared to other treatments.
Phase III trials are large, frequently multi-institution tests. They generally compare the relative value of the new drug compared with the current standard treatment and measure whether a new drug extends survival or otherwise improves the health of patients on treatment (clinical improvement) rather than just provide surrogate marker data. These studies generally last longer and are larger than phase II trials.
(31 Dec 1997)
phase image A magnetic resonance image showing only phase shift information, to detect motion.
(05 Mar 2000)
phase plate <microscopy> The plate used near the back focal plane of a microscope objective lens (in conjunction with an annulus at the front focal plane of the condenser lens) to achieve phase contrast. The phase plate selectively shifts the phase of the waves diffracted by the specimen by a quarter wave and reduces the amplitude of the undeviated, direct beam.
(05 Aug 1998)
phase, resting More appropriately called interphase. The interval in the cell cycle between two cell divisions when the individual chromosomes cannot be distinguished, interphase was once thought to be the resting phase but it is far from a time of rest for the cell. It is the time when DNA is replicated in the cell nucleus.
(12 Dec 1998)
phase rule An expression of the relationships existing between systems in equilibrium: P + V = C + 2, where P is the number of phases, V the variance or degrees of freedom, and C the number of components; it also follows that the variance is, V = C + 2 -P. For H2O at its triple point, V = 1 + 2 -3 = 0, i.e., both temperature and pressure are fixed.
Synonym: Gibb's phase rule.
(05 Mar 2000)
phase separation <chemistry> The separation of fluid phases that contain different concentrations of common components.
Occurs with partially miscible solvents used in many biochemical separation methods. Also temperature dependent phase separation occurs with some detergent solutions. With reference to membranes means the segregation of lipid components into domains that have different chemical composition.
(31 Dec 1997)
phase variation <microbiology> Alteration in the expression of surface antigens by bacteria.
For example: Salmonella can express either of two forms of flagellin, H1 and H2, that are coded by different genes. Control of which form is expressed is brought about by inversion of the promoter for the H2 gene, which if functional (noninverted) is associated with the expression of H2 and the production of a repressor of the H1 gene.
Inversion occurs about every 1000 bacterial divisions and is under the control of another gene, hin, that is within the invertable sequence.
(31 Dec 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
ÅëÇÕ°Ë»ö ¿Ï·á